European Neurologic-Monitoring Market

The increasing prevalence of neurologic problems, concomitant with technology advances, are supporting high-growth potential in the European neurologic-monitoring market.

The rising incidence of epilepsy in developed nations and heightened awareness about sleep disorders, coupled with the rapid rise of sleep labs and sleep clinics, has greatly motivated and influenced the growth of the neurologic-monitoring market in such disorders. However, the presence of well established participants and market saturation, together with a stagnant competitive landscape, is posing a serious challenge for newer companies to enter the market.

"Neurological monitoring is a technologically advanced market and is poised to revolutionize the monitoring of neurological parameters,” said C.R. Hema Varishika, a research analyst with Frost & Sullivan (Palo Alto, CA, USA), an international consulting company. "Market participants have shifted their focus towards new applications, like long-term monitoring of conditions such as epilepsy and sleep disorders that will drive market growth.”

"In this market with rising health expenditures and an unstable economy, tactical and well calculated measures have to be taken to develop and promote one's products,” cautioned Ms. Varshika. "Product development initiatives need to be based on research in emerging areas and be supported by strategic marketing. Proactive alliances and tactical marketing plans followed by effective execution will enable expansion in market share.”

According to Frost & Sullivan, the European neurologic-monitoring market earned revenues of $135.2 million in 2005 and is anticipated to reach $175.3 million in 2012.



Related Links:
Frost & Sullivan